Retrospective, multicenter, non-profit observational study. The study will include consecutive patients who underwent lower-limb megaprosthesis implantation at the participating Centers between January 1, 2020, and June 30, 2023.
Age ≥ 14 years
Implantation of a lower-limb megaprosthesis at one of the participating centers between January 1, 2020, and June 30, 2023
At least 2 years of follow-up after megaprosthesis implantation
Signed informed consent
None
All patients aged 14 years or older who underwent implantation of a lower-limb megaprosthesis at the participating Centers between January 1, 2020, and June 30, 2023, will be included.
Cohort
Retrospective
Not listed
Percent of patients with and without a diagnosis of megaprosthesis infection
Distribution of the study variables in the two groups of patients with and without megaprosthesis infection
Number of patients diagnosed with lower-limb megaprosthesis infection / number of patients who received a lower-limb megaprosthesis
Sex, Charlson index, indication for prosthesis placement, symptoms and etiology of the infection in patients diagnosed with megaprosthesis infection
Age of patients diagnosed with megaprosthesis infection
Number and type of surgical procedures performed for the treatment of megaprosthesis infection
Click on the lead sponsor to view all of their trials.
